41st Annual J.P. Morgan Healthcare Conference

NEVER STOP Innovating For a Healthier World

Teiichi Goto

President CEO

FUJIFILM Holdings Corporation

January 10, 2022

Forward-looking statements

Forward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are management's current assumptions and beliefs based on currently available information. Such forward-looking statements are subject to a number of risks, uncertainties and other factors. Accordingly, actual results may differ materially from those projected due to various factors.

© FUJIFILM Holdings Corporation 2

Corporate Philosophy

We will use leading-edge, proprietary technologies to provide top-quality products and services that contribute to the advancement of culture, science, technology and industry, as well as improved health and environmental protection in society.

Our overarching aim is to help enhance the quality of life of people worldwide.

Corporate Slogan

© FUJIFILM Holdings Corporation 3

FUJIFILM Snapshot

Fujifilm has been evolving and transforming for more than 80 years. We will NEVER STOP innovating to improve the quality of healthcare.

FUJIFILM Holdings Group total

75,474

Employees as of March 31, 2022

169

Countries served

¥229.7 billion

Operating income (FY2021) OPM9.1%

53,894

Number of patents owned

¥ 364.5 billion

Growth investment (R&D|Capex FY2021)

Revenue by Segment

¥2,525.8 billion ($ 22.4 billion)

Healthcare

¥801.7 billion

($7.1 billion)

(OPM 12.5%)

Imaging

13%

Medical systems

Revenue

66%

composition

FY2021

Bio CDMO

Business

Healthcare

19%

Innvovation

32%

15%

30%

LS Solutions

(+5.4% YoY)

Materials

25%

13 %

Revenue by Region

39 %

5 %

Europe

Japan

Others

13 %

9 %

21 %

China

Asia

The Americas

*FY2021 Foreign Exchange(FX) assumption (Actual): US$ = JPY 113 *Fujifilm's fiscal year begins on April 1 and ends on March 31

© FUJIFILM Holdings Corporation 4

FUJIFILM's Healthcare

In the areas of prevention, diagnosis and treatment, we will help create a healthy society by resolving social issues, including by addressing unmet medical needs and improving access to medical services.

Prevention

Diagnosis

Treatment

Bulk Drug Substance for Vaccine

Diagnostic Imaging Systems

Bio CDMO

Functional Cosmetics

Medical IT

Cell/Gene Therapy

Supplements

Endoscopes

Cell Culture Media

In-vitro Diagnosis

Pharmaceuticals

Ultrasound Systems

Small-molecule CDMO

© FUJIFILM Holdings Corporation 5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Fujifilm Holdings Corporation published this content on 06 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 January 2023 08:40:28 UTC.